Evidence map›Paper›PMID 32260442›Full record

ReviewInternational journal of molecular sciences2020

Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability.

Alejandra Koeneke, Guillermo Ponce, Johanna Troya-Balseca, Tomás Palomo, Janet Hoenicka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Functions of the RIP kinase family members in the skin.Cellular and molecular life sciences : CMLS · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Pharmacogenetics of Addiction Therapy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Comparative and evolutionary analysis ofFrontiers in genetics · 2022
    Article
  12. Frontiers in neuroscience · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Alejandra KoenekeDepartamento de Psicología, Facultad de Ciencias Biomédicas, Universidad Europea Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.ORCID 0000-0002-1970-787X
Guillermo PonceServicio de Psiquiatría, Hospital Universitario 12 de Octubre, Av. de Córdoba s/n, 28041 Madrid, Spain.
Johanna Troya-BalsecaLaboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.
Tomás PalomoDepartamento de Medicina Legal, Psiquiatría y Patología, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Janet HoenickaLaboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0002-6790-6988
Hospital Sant Joan de Déu Barcelona · ESUniversidad Complutense de Madrid · ESHospital Universitario 12 De Octubre · ES

Funding

Instituto de Salud Carlos III PI015/01013Instituto de Salud Carlos III PI019/00126
6 · The paper itself

Abstract

The

Indexed as

Behavior, AddictiveCentral Nervous SystemEpistasis, GeneticHumansPolymorphism, Single NucleotideProtein Serine-Threonine KinasesReceptors, Dopamine D2Substance-Related DisordersTissue DistributionANKK1 protein, humanDRD2 protein, humanProtein Serine-Threonine KinasesReceptors, Dopamine D2addictionsANKK1dopamineDRD2neurodevelopmentTaqIA

Identifiers

PMID32260442
PMCPMC7177674
OpenAlexW3014697086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.